Research Alliance Corporation IV

Profile

Research Alliance Corporation IV is a special purpose acquisition company focused on the healthcare and life sciences sectors. Sponsored by an affiliate of RA Capital Management, the company is organized as a blank check vehicle to carry out a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more operating businesses. Its mandate concentrates on healthcare-related industries, with particular emphasis on drug development and commercialization, diagnostics, healthcare technology, and healthcare services, giving it exposure to both biopharmaceutical innovation and enabling healthtech platforms. Headquartered in New York, New York and founded in 2026, Research Alliance Corporation IV operates in the capital markets as an intermediary between institutional and public investors and private or growth-stage healthcare companies seeking access to public market capital and liquidity. Led by an experienced management team with scientific and financial backgrounds, it plays a targeted role in the SPAC segment of the market by sourcing, evaluating, and structuring transactions within the global healthcare and life sciences ecosystem.